Summary
Johnson & Johnson's 2002 Form 10-K paints a picture of a diversified healthcare giant operating across three key segments: Consumer, Pharmaceutical, and Medical Devices & Diagnostics. The company's robust market position is underscored by its significant market capitalization, exceeding $156 billion in early 2003, indicating strong investor confidence. While the filing itself doesn't provide detailed financial performance for 2002, it outlines the organizational structure and regulatory environment JNJ operates within, highlighting its compliance with filing requirements and its status as an accelerated filer. Investors should note the comprehensive nature of JNJ's business, with operations spanning global markets and a focus on research and development to maintain its competitive edge. The company's reliance on patents and trademarks emphasizes the importance of innovation and intellectual property protection. The filing also acknowledges the highly regulated nature of the pharmaceutical and medical device industries, suggesting potential impacts from regulatory changes and legal proceedings, which are detailed further in the report.
Key Highlights
- 1Johnson & Johnson is a diversified healthcare company with three primary business segments: Consumer, Pharmaceutical, and Medical Devices & Diagnostics.
- 2The company held a significant market capitalization of approximately $156 billion as of the last business day of its second fiscal quarter, reflecting strong investor confidence.
- 3JNJ is classified as an accelerated filer, indicating its substantial size and compliance with SEC reporting requirements.
- 4The company's business is heavily reliant on patents and trademarks, underscoring the importance of innovation and intellectual property.
- 5Operations are global, with the company participating in various geographic markets.
- 6The filing acknowledges the importance of research and development in maintaining competitiveness.
- 7The highly regulated nature of the pharmaceutical and medical device industries is a key operating factor.